dr. pagel on determining treatment based on genetic risk in double- and triple-hit lymphoma
Published 3 years ago • 425 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
1:34
dr. smith discusses double-hit and triple-hit lymphoma
-
1:29
dr. rutherford on double-hit and double-expressor lymphomas
-
1:28
dr. pagel on the shift toward precision medicine in large cell lymphoma
-
1:43
dr. smith discusses the diagnosis of double-hit lymphoma
-
1:28
dr. smith advises clinicians on diagnosing double-hit and triplet-hit lymphoma
-
24:24
double-hit dlbcl
-
6:44
prognostic factors in dlbcl
-
4:31
how to treat double-hit lymphoma?
-
1:09
areas of unmet need for dlbcl: primary refractory disease and double-hit lymphoma
-
23:58
double hit lymphoma - what is it and how should we treat it?
-
18:04
what is the best approach to treat double hit/double protein expression dlbcl?
-
3:55
ash impact series: jonathan friedberg, md - how to treat highly aggressive lymphomas
-
14:57
how does the prognostic outlook for patients with double-hit lymphoma impact disease management?
-
5:40
optimization of pet scans and determining relapse in dlbcl
-
18:54
how should we treat double hit and double expressor dlbcl?
-
1:47
dr. rutherford on the importance of including patients with double-hit lymphoma in clinical trials
-
1:34
the standard of care for dlbcl and double-hit lymphoma
-
3:27
double hit lymphoma: a challenge for lymphoma experts
-
0:57
outcomes of patients with double-hit lymphoma treated with car-t therapy